Evaluating the safety and efficacy of recombinant human thrombopoietin among severe sepsis patients with thrombocytopenia: study protocol for a randomized controlled trial

Overview of attention for article published in Trials, May 2015

Altmetric Badge

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 17,739 followers.

Evaluating the safety and efficacy of recombinant human thrombopoietin among severe sepsis… https://t.co/BzdjFfYkd0 https://t.co/lzC5KAK2A3

Reply Repost Favourite

Evaluating the safety and efficacy of recombinant human thrombopoietin among severe #sepsis patients…study:http://t.co/fGQZj57MSi

Reply Repost Favourite

Evaluating the safety and efficacy of recombinant human thrombopoietin among severe #sepsis patients…study:http://t.co/fGQZj57MSi

Reply Repost Favourite

Evaluating the safety and efficacy of recombinant human thrombopoietin among severe #sepsis patients…study:http://t.co/fGQZj57MSi

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.